Mark van Oene
Chief Operating Officer bij PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Vermogen: 6 M $ op 31-03-2024
Profiel
Mark David Van Oene bekleedt de functie van Chief Operating Officer bij Pacific Biosciences of California, Inc. Hij zit ook in de raad van bestuur van BlueGnome Ltd. en Illumina Cambridge Ltd. Daarvoor was hij Chief Commercial Officer & Senior Vice President bij Illumina, Inc. en Director-Genotyping Services bij Ellipsis Biotherapeutics Corp. Hij behaalde een bachelorgraad aan de University of Western Ontario en een doctoraat aan de University of Toronto.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-03-2024 | 1 668 826 ( 0.62% ) | 6 M $ | 31-03-2024 |
Actieve functies van Mark van Oene
| Bedrijven | Functie | Begin |
|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Chief Operating Officer | 08-01-2021 |
Illumina Cambridge Ltd.
 Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom. | Director/Board Member | - |
BlueGnome Ltd.
 BlueGnome Ltd. Packaged SoftwareTechnology Services BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom. | Director/Board Member | 22-01-2018 |
Dante Labs, Inc.
 Dante Labs, Inc. Medical/Nursing ServicesHealth Services Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY. | Director/Board Member | 24-08-2021 |
Eerdere bekende functies van Mark van Oene
| Bedrijven | Functie | Einde |
|---|---|---|
Ellipsis Biotherapeutics Corp.
 Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The private company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Corporate Officer/Principal | - |
| ILLUMINA, INC. | Corporate Officer/Principal | - |
Opleiding van Mark van Oene
| University of Toronto | Doctorate Degree |
| University of Western Ontario | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
BlueGnome Ltd.
BlueGnome Ltd. Packaged SoftwareTechnology Services BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom. | Technology Services |
Ellipsis Biotherapeutics Corp.
Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The private company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Commercial Services |
Dante Labs, Inc.
Dante Labs, Inc. Medical/Nursing ServicesHealth Services Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY. | Health Services |
Illumina Cambridge Ltd.
Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom. | Commercial Services |
